Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $72,522 - $118,518
1,596 Added 0.34%
477,832 $31.4 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $8.98 Million - $17.6 Million
217,078 Added 83.76%
476,236 $21.4 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $1.19 Million - $1.87 Million
16,502 Added 6.8%
259,158 $18.8 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $359,874 - $470,684
4,127 Added 1.73%
242,656 $26 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $2.96 Million - $3.92 Million
31,471 Added 15.2%
238,529 $26.5 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $6.94 Million - $8.07 Million
-58,028 Reduced 21.89%
207,058 $26.5 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $89,191 - $116,299
817 Added 0.31%
265,086 $35.3 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $56,090 - $64,670
559 Added 0.21%
264,269 $28.6 Million
Q1 2021

Apr 29, 2021

BUY
$101.51 - $125.27 $360,258 - $444,583
3,549 Added 1.36%
263,710 $27.8 Million
Q4 2020

Feb 02, 2021

SELL
$85.88 - $105.36 $3.11 Million - $3.82 Million
-36,252 Reduced 12.23%
260,161 $27.1 Million
Q3 2020

Nov 03, 2020

BUY
$72.74 - $92.5 $4,873 - $6,197
67 Added 0.02%
296,413 $25.4 Million
Q2 2020

Aug 05, 2020

BUY
$48.02 - $79.04 $8,019 - $13,199
167 Added 0.06%
296,346 $21.7 Million
Q1 2020

Apr 29, 2020

BUY
$36.95 - $62.95 $789,621 - $1.35 Million
21,370 Added 7.78%
296,179 $15.4 Million
Q4 2019

Jan 23, 2020

BUY
$47.06 - $56.64 $12.9 Million - $15.6 Million
274,809 New
274,809 $15.5 Million
Q4 2019

Jan 22, 2020

SELL
$47.06 - $56.64 $12.7 Million - $15.3 Million
-270,462 Closed
0 $0
Q3 2019

Oct 24, 2019

BUY
$47.45 - $58.05 $1.21 Million - $1.48 Million
25,412 Added 10.37%
270,462 $13.2 Million
Q2 2019

Jul 26, 2019

BUY
$39.26 - $54.21 $9.62 Million - $13.3 Million
245,050 New
245,050 $13.6 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Ironvine Capital Partners, LLC Portfolio

Follow Ironvine Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironvine Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironvine Capital Partners, LLC with notifications on news.